首页> 外文OA文献 >Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping

【2h】

Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping

机译：通过分子亚型预测的前瞻性新辅助乳腺癌登记注册交响乐试验（NBRST）对临床发光型乳腺癌患者的化学敏感性和内分泌敏感性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Pat Whitworth; Peter Beitsch; Angela Mislowsky; James V. Pellicane; Charles Nash; Mary Murray; Laura A. Lee; Carrie L. Dul; Michael Rotkis; Paul Baron; Lisette Stork-Sloots; Femke A. de Snoo; Jennifer Beatty;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping [J] . Pat Whitworth, Peter Beitsch, Angela Mislowsky, Annals of surgical oncology . 2017,第3期

机译：分子亚型预测临床腔乳腺癌患者临床乳腺癌患者中的化学敏感性和内分泌敏感性
2. Chemosensitivity predicted by BluePrint 80-gene functional subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST). [J] . Pat Whitworth, Lisette Stork-Sloots, Femke A de Snoo, Annals of surgical oncology . 2014,第10期

机译：由BluePrint 80基因功能亚型和MammaPrint预测的化学敏感性在前瞻性新辅助乳腺癌登记系统交响乐试验（NBRST）中。
3. Chemosensitivity predicted by BluePrint 80-gene functional subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST). [J] . Pat Whitworth, Lisette Stork-Sloots, Femke A de Snoo, Annals of surgical oncology . 2014,第10期

机译：Blueprint 80-基因功能亚型和Mammaprint预测的化学敏感性在预期的Neoadjuvant乳房注册表交响曲 - 交响曲试验（NBRST）中。
4. Translating Multiscale Cancer Models into Clinical Trials: Simulating Breast Cancer Tumor Dynamics within the Framework of the "Trial of Principle" Clinical Trial and the ACGT Project [C] . Eleni A. Kolokotroni, Georgios S. Stamatakos, Dimitra D. Dionysiou, IEEE International Conference on BioInformatics and BioEngineering . 2008

机译：将MultiSscale癌症模型转化为临床试验：在“原理试验”临床试验和ACGT项目的框架内模拟乳腺癌肿瘤动态
5. Molecular subtypes of estrogen receptor positive breast cancers predict clinical behavior. [D] . Kerr, Daniel Alan, II. 2010

机译：雌激素受体阳性乳腺癌的分子亚型可预测临床行为。
6. Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping [O] . Pat Whitworth, Peter Beitsch, Angela Mislowsky, -1

机译：通过分子亚型预测的前瞻性新辅助乳腺癌登记注册交响乐试验（NBRST）对临床发光型乳腺癌患者的化学敏感性和内分泌敏感性
7. Chemosensitivity Predicted by BluePrint 80-Gene Functional Subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) [O] . 2014

机译：由BluePrint 80基因功能亚型和MammaPrint预测的化学敏感性在前瞻性新辅助乳腺癌登记系统交响乐试验（NBRST）中

Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping

著录项

相似文献

相关主题

期刊订阅